Nanomedicines in the European translational process-Reference-Cited by-同舟云学术

Nanomedicines in the European translational process

Published:2015-01-01 Issue:3 Volume:7 Page:
ISSN:1662-596X
Container-title:European Journal of Nanomedicine
language:
Short-container-title:

Author:

Bremer-Hoffmann Susanne,Amenta Valeria,Rossi François

Abstract

AbstractIn 2013, the World Health Organisation (WHO) released an update of the report on “Priority Medicines for Europe and the World” with the aim to bridge the gap between public health needs and the current research and development priorities. A number of emerging technologies are currently explored for their potential to respond to the identified unmet medical needs. Nanotechnology has the potential to offer scientific/technical solutions for some of these pharmaceutical gaps. The present report investigates to what extent projects funded by the European Commission will lead to innovative formulations as well as new therapeutic concepts, if clinical studies in European Member States investigating nanomedicines and finally if nanotech based products authorised in the European Union will contribute to identified public health needs.

Publisher

Walter de Gruyter GmbH

Subject

Physical and Theoretical Chemistry,Biomedical Engineering,Medicine (miscellaneous),Bioengineering

Link

https://www.degruyter.com/document/doi/10.1515/ejnm-2015-0027/pdf

Reference50 articles.

1. Scientific Committee on Emerging and Newly Identified Health Risks Guidance on the Determination of Potential Health Effects of Nanomaterials Used in Medical Devices opinion on the Guidance on the Determination of Potential Health Effects of Nanomaterials

2. Closing the gap : accelerating the translational process in nanomedicine by proposing standardized characterization techniques;Khorasani;Int J Nanomed,2014

3. in cancer therapy challenges opportunities clinical applications;Wicki;Nanomedicine J Control Release

4. European Medicines Agency Withdrawal assessment report for sinerem Cited Available from http www ema europa eu docs en GB document library Application withdrawal assessment report WC pdf,2010

5. European Medicines Agency Reflection paper on nanotechnology - based medicinal products for human use Cited Available from http www ema europa eu docs en GB document library Regulatory and procedural guideline WC pdf,2010

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Magnetoliposomes Based on Magnetic/Plasmonic Nanoparticles Loaded with Tricyclic Lactones for Combined Cancer Therapy;Pharmaceutics;2021-11-10

2. Nanopharmaceutics: Part II—Production Scales and Clinically Compliant Production Methods;Nanomaterials;2020-03-04

3. Magnetoliposomes Containing Calcium Ferrite Nanoparticles for Applications in Breast Cancer Therapy;Pharmaceutics;2019-09-14

4. Overview of Techniques and Description of Established Processes;Pharmaceutical Nanotechnology: Innovation and Production;2016-12-02

5. The Emergence of Nanopharmacy: From Biology to Nanotechnology and Drug Molecules to Nanodrugs;Pharmaceutical Nanotechnology: Innovation and Production;2016-12-02